Cargando…
The role of TNF inhibitors in psoriasis therapy: new implications for associated comorbidities
Over the past several years, tumor necrosis factor (TNF) antagonists have become first-line agents in the treatment of moderate-to-severe psoriasis. These medications are highly effective in treating both psoriasis and psoriatic arthritis and may also reduce the risk of cardiovascular events in pati...
Autores principales: | Yost, John, Gudjonsson, Johann E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medicine Reports Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924720/ https://www.ncbi.nlm.nih.gov/pubmed/20948750 http://dx.doi.org/10.3410/M1-30 |
Ejemplares similares
-
Psoriasis and the MAITing game: A role for IL-17A+ invariant TCR CD8+ T cells in psoriasis?
por: Johnston, Andrew, et al.
Publicado: (2014) -
Psoriasis: new comorbidities
por: Machado-Pinto, Jackson, et al.
Publicado: (2016) -
Psoriasis: Comorbidities
por: Yamazaki, Fumikazu
Publicado: (2021) -
Comorbid Psoriasis and Metabolic Syndrome: Clinical Implications and Optimal Management
por: De Brandt, Eveline, et al.
Publicado: (2022) -
Role of Janus Kinase Inhibitors in Therapy of Psoriasis
por: Słuczanowska-Głąbowska, Sylwia, et al.
Publicado: (2021)